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Predictors of Postoperative Quality of Life after Surgery for
Lung Cancer
Axel Mo¨ller* and Ulrik Sartipy, MD, PhD†‡
Introduction: The aim was to analyze the association between
selected patient variables and health-related quality of life 6 months
after surgery for lung cancer.
Methods: In a prospective population-based cohort study, Short
Form 36 (SF-36) was used to assess quality of life before and 6
months after surgery for lung cancer. The change in SF-36 summary
and subscale scores were used to categorize quality of life in two
groups (worse or stable/improved) at 6 months compared with
baseline. Logistic regression models adjusting for potential con-
founding factors were used to analyze the association between
patient variables and quality of life 6 months after surgery.
Results: A baseline SF-36 questionnaire was completed by 249
patients. Nonresponders at 6 months (n 36) were excluded, and 14
patients who died before 6 months follow-up remained in the study,
leaving 213 patients available for analysis. Gender, comorbidity,
occurrence of postoperative complications, and tumor stage were not
associated with the physical aspect of quality of life 6 months after
surgery. The extent of resection, age, and adjuvant therapy was
significantly associated with a clinically relevant decline in the
SF-36 physical component summary score 6 months postopera-
tively. No patient variables were predictive of a decline in the mental
component summary score.
Conclusions: The extent of resection, age, and adjuvant therapy was
associated with a clinically relevant decline in the physical aspect of
health-related quality of life 6 months after surgery. Further studies
are needed to explore possible mechanisms.
Key Words: Quality of life, Surgery, Lung cancer.
(J Thorac Oncol. 2012;7: 406–411)
Although surgical resection is the best treatment for local-ized cancer of the lung, a large operation may have
impact on the health-related quality of life (QOL), both early
after surgery and in the long run. There are conflicting data
regarding changes in QOL during the first postoperative
year1–6; however, current evidence suggests long-lasting lim-
itations in the physical domain, but a partial recovery of
mental or emotional capabilities.7–10 Risk estimation for in-
hospital death after pulmonary resection can be performed
using the Thoracoscore model.11,12 However, in addition to
information regarding risk of death or postoperative compli-
cations, patients require information regarding the risk of
experiencing a significant reduction in their QOL.13 Objective
functional measures such as tests of lung function or exercise
capacity do not satisfactorily predict QOL after surgery,3,14–16
and it is reasonable to conclude that it is necessary to use a
validated instrument designed for QOL assessment to im-
prove the level of understanding in this field.
We performed a prospective population-based cohort
study to investigate health-related QOL at baseline and 6
months after lung surgery. This exploratory study exam-
ines the hypothesis that a clinically relevant decline in
certain aspects of health-related QOL can be predicted by
factors known before or early after surgery. The aim was
to analyze the association between selected patient and
tumor characteristics and QOL 6 months after surgery for
lung cancer.
MATERIALS AND METHODS
From April 2006 to April 2008, 249 patients scheduled
for lung surgery at the Karolinska University Hospital were
included in a prospective population-based cohort study.
Karolinska University Hospital is the only referral center for
thoracic surgery in Stockholm County with an approximate
population of 2 million.
Health-related QOL was assessed with the use of the
Medical Outcomes Study 36-Item Short Form 36 (SF-36)
questionnaire (Swedish Version 1.0).17,18 The SF-36 evalu-
ates eight dimensions of health: physical functioning, role
limitations due to physical problems, bodily pain, vitality,
general health perception, social function, role limitations due
to emotional problems, and mental health. Scores for each
domain range from 0 to 100, with higher scores indicating
better health status. Also, the SF-36 provides summary scales
for overall physical and mental health-related QOL with the
use of norm-based methods.19 Again, higher scores indicate
better health status.
All patients completed the baseline SF-36 question-
naire. Most patients completed the questionnaire on the day
before surgery, and a small number of patients completed the
questionnaire 2 to 4 days before surgery. Six months after the
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operation, the SF-36 questionnaire was mailed to the patients,
and they were asked to fill out and return the questionnaire by
mail. A reminder was sent out after 1 month to those patients
who had not returned the second questionnaire, and a final
reminder was sent 1 month later.
Patient and tumor characteristics and operative and
postoperative details were prospectively collected and en-
tered into a database.
The study was approved by the regional Human Re-
search Ethics Committee, Stockholm, Sweden (Dnr: 2006/
359-31/3). Informed consent was obtained from all patients.
Statistical Analyses
For the purpose of this study, the SF-36 summary and
subscale scores were dichotomized into “stable or improved”
versus “worse.” Patients with a summary score reduction of
10% or more were categorized as worse, and otherwise as
stable or improved. Patients with a subscale score reduction
of 10 points or more were categorized as worse, and other-
wise as stable or improved. Moreover, patients who died
before reaching 6 months of follow-up, and thus unable to
complete the second questionnaire, were categorized as
worse. Logistic regression models were used to analyze
associations between patient variables and QOL 6 months
after surgery. We report OR and 95% confidence intervals
(CIs). A final multivariable model was created, adjusting for
age (two groups: younger or older than 65 years), gender,
comorbidity, extent of resection (three groups: pneumonec-
tomy, lobectomy, or sublobar resection), postoperative com-
plication, adjuvant therapy, and tumor stage (two groups:
stage 0 to I or stage II to III), and the corresponding baseline
SF-36 summary or subscale score as a continuous variable. If
the patients had any comorbidity, they were classified as
“Comorbidity: Yes”, and otherwise as “Comorbidity: No.”
Comorbidity was defined as the presence of any of ischemic
heart disease, hypertension, congestive heart disease, diabetes
mellitus, peripheral vascular disease, or cerebrovascular dis-
ease. Ischemic heart disease was defined as a history of
angina pectoris, myocardial infarction, or revascularization
procedure (coronary artery bypass surgery or percutaneous
coronary intervention). Hypertension was defined as a history
of high blood pressure requiring medication. Congestive
heart disease was defined as a history of heart failure or left
ventricular ejection fraction less than 0.5. Diabetes mellitus
was defined as diabetes requiring insulin or oral antidiabetics.
Peripheral vascular disease was defined as a history of clau-
dication, carotid stenosis, or abdominal aneurysm. Cerebro-
vascular disease was defined as a history of stroke or transient
ischemic attack. If the patients had any complication, they
were classified as Complication: Yes, and otherwise as Com-
plication: No. Complication was defined as any of the fol-
lowing postoperative complications: new onset atrial fibrilla-
tion, prolonged air leak (chest tubes in place for more than 5
days), pneumonia, reintubation, reoperation, or hospital stay
of 8 days or more. Statistical analyses were performed using
IBM SPSS Statistics 19 (IBM; Armonk, NY).
RESULTS
Study Population
We included 249 patients who completed the baseline
SF-36 questionnaire. During 6 months of follow-up, 14 pa-
tients died and remained in the study categorized as worse in
all summary and subscale score groups. For various reasons,
36 patients did not complete the second questionnaire, so the
total study population for final analysis was 213 patients, and
the dropout rate was 14% (36/249).
The characteristics of the study population are presented
in Table 1. Operation type, postoperative data, tumor stage, and
histopathology are shown in Table 2. The mean age of the study
population was 65 years, and half were women. The majority
underwent lobectomy and the most common histopathology was
adenocarcinoma. About one third had adjuvant radio- or che-
motherapy. Eleven patients underwent video-assisted thoraco-
scopic surgery. All other patients had a muscle-sparing pos-
terolateral thoracotomy. Postoperative management included
thoracic epidural analgesia.
Associations Between Patient Variables and
SF-36 Summary Scores
Fifty-nine percent of the patients reported worse phys-
ical component summary score, and 33% reported worse
mental component summary score 6 months after surgery
compared with baseline (Table 3). Gender, comorbidity,
occurrence of postoperative complications, and tumor stage
were not significantly associated with a reduction in the
physical aspect of QOL 6 months after surgery. However, the
extent of resection (lobectomy OR: 2.29, 95% CI: 1.02–5.17
and pneumonectomy OR: 5.60, 95% CI: 1.29–24.2), age
older than 65 years (OR: 1.95, 95% CI: 1.02–3.71), and
adjuvant therapy (OR: 2.23, 95% CI 1.01–4.90) were signif-
icantly associated with a worse physical aspect of QOL 6
months postoperatively. There were no significant associa-
TABLE 1. Preoperative Characteristics
Variable Mean (SD) or n (%)
Age (yr) 64.8 (10.8)
Women 104 (49)
Body mass index (kg/m2) 25.3 (4.1)
Ischemic heart disease 20 (9.4)
Hypertension 67 (32)
Congestive heart disease 2 (0.9)
Diabetes mellitus 18 (8.5)
Peripheral vascular disease 10 (4.7)
Cerebrovascular disease 6 (2.8)
Smoking statusa
Current smoker 73 (34)
Former smoker 93 (44)
Never smoker 31 (14)
a Smoking status was divided into three categories: current, former, and never
smoker. Current smoker was defined as an active smoker or a person who had stopped
smoking within 1 year of surgery. Former smoker was defined as a previous smoker
who had stopped smoking more than 1year before surgery. Never smoker was defined
as a person who had never been an active smoker.
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tions between any of the patient variables and worse mental
aspect of QOL 6 months after surgery (Table 3).
Associations Between Patient Variables and
SF-36 Subscale Scores
Between 34 and 52% of the patients reported worse
QOL according to the SF-36 subscale scores 6 months after
surgery compared with baseline (Table 4). Gender, comor-
bidity, and tumor stage were not significantly associated with
a clinically relevant reduction in any of the SF-36 subscales
6 months after surgery. There was a significantly higher risk
for deterioration in the physical role functioning subscale in
patients older than 65 years compared with younger patients
(OR: 3.13, 95% CI: 1.63–6.00). Patients who underwent
pneumonectomy had a higher risk of impaired QOL in the
physical functioning (OR: 31.3, 95% CI: 3.44–286), physical
role functioning (OR: 4.04, 95% CI: 1.10–14.8), general
health (OR: 4.46, 95% CI: 1.18–16.8), and vitality (OR: 8.89,
95% CI: 2.21–35.8) subscales compared with patients who
underwent sublobar resections. The consequence of suffering
a postoperative complication was a significantly higher risk
of impairment in the physical functioning (OR: 2.56, 95% CI:
1.14–5.74), general health (OR: 2.19 95% CI: 1.04–4.61),
and social functioning (OR: 3.32, 95% CI: 1.57–7.02) sub-
scales, compared with patients without postoperative compli-
cations. Finally, in patients receiving adjuvant therapy, there
was an increased risk for worse QOL in the physical func-
tioning (OR: 3.76, 95% CI: 1.72–8.22), physical role func-
tioning (OR: 2.85, 95% CI: 1.28–6.36), vitality (OR: 3.34,
95% CI: 1.48–7.51), and social functioning (OR: 3.09, 95%
CI: 1.48–6.46) subscales compared with patients without
adjuvant treatment (Table 4).
DISCUSSION
The main findings were that patients who underwent
either lobectomy or pneumonectomy compared with a less
extensive resection, or were older than 65 years, or received
adjuvant therapy compared with those who did not, had a
higher risk for a clinically relevant decline in the physical
aspect of QOL 6 months after surgery for lung cancer.
Gender, comorbidity, occurrence of postoperative complica-
tions, and tumor stage were not significantly associated with
a reduction in the physical aspect of QOL. None of the
variables in the model was significantly associated with a
clinically relevant reduction in the mental aspect of QOL.
Patients who received adjuvant therapy had a significantly
higher risk for a clinically relevant decrease in QOL in four
of the SF-36 subscales, and the extent of resection was
associated with a higher risk for a worsening in four of the
SF-36 subscales. A postoperative complication was associ-
ated with an increased risk for a decline in three of the SF-36
subscales, and age older than 65 years predicted a meaningful
reduction in one of the SF-36 subscales. Tumor stage, pre-
operative comorbidity, and gender were not associated with a
clinically relevant decrease in any of the SF-36 subscales.
The prospective population-based design of our study,
together with a high response rate, offered a reduced risk of
selection bias and enhanced the external validity. However,
we cannot completely rule out that the nonresponding pa-
tients at 6 months to a limited extent could have influenced
the results. Another strength was the longitudinal design,
making it possible to analyze the change in QOL before and
6 months after surgery, while adjusting for the corresponding
baseline summary or subscale score in the regression models.
We defined a clinically relevant worsening in QOL as a
SF-36 summary score increase of 10% or more between
baseline and 6 months after surgery. However, there is no
universal method for defining the clinical significance or even
the minimally important difference of QOL data.20 One way
of defining a clinically significant change in QOL is a
difference score that is large enough to have an implication
for the patient’s treatment or care.21 Other investigators have
used an analogous definition of a clinically relevant differ-
ence in a large randomized clinical trial.22
Several studies have investigated the effect of a single
variable on postoperative QOL: age,1,4,23,24 gender,25 smok-
ing cessation,26 and extent of resection.2,8,27,28 On the other
hand, only a few studies have focused on identifying predic-
tors for QOL after lung surgery.29,30 Pompili et al. assessed
QOL using SF-36 in 172 patients before and 3 months after
lung surgery and derived predictive equations estimating the
decline in postoperative QOL.30 The equation predicting the
risk of a decline in the physical component summary score
contained three SF-36 subscale scores: physical functioning,
TABLE 2. Postoperative Data, Tumor Stage, and Histology
Variable n (%)
Operation
Pneumonectomy 20 (9.4)
Lobectomy 147 (69)
Thoracotomy, sublobar resection,
or other procedure
35 (16)
VATS 11 (5.2)
Side
Right 116 (54)
Left 97 (46)
Adjuvant chemotherapy 59 (28)
Adjuvant radiotherapy 16 (7.5)
Atrial fibrillationa 9 (4.2)
Prolonged air leakb 15 (7.0)
Pneumonia 7 (3.3)
Hospital stay 8 d 37 (17)
Stages I–II 134 (63)
Stage III 18 (8.5)
Histology
Adenocarcinoma 101 (47)
Squamous cell carcinoma 21 (9.9)
Large cell carcinoma 9 (4.2)
Carcinoid 15 (7.0)
Other malignancy 10 (4.7)
Metastasis 24 (11)
Benign 33 (15)
a New onset.
b Chest tubes in place for more than 5 d.
VATS, video-assisted thoracoscopic surgery.
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bodily pain, and mental health. The equation predicting the risk
of a decline in the mental component summary score included
predicted postoperative forced expiratory volume in 1 second
and two SF-36 subscale scores: social functioning and mental
health. In a study of 72 patients, Barle´si and coworkers found
that patients with a low preoperative Psychological Global Well
Being Index had statistically significant lower global QOL,
physical, and emotional functional scores according to the Eu-
ropean Organization for Research and Treatment of Cancer
QOL Questionnaire, 1 month after surgery.29
Our finding of an increased risk for a worse physical
aspect of QOL among patients receiving adjuvant therapy is
contrasting to prior studies. Handy5 reported that adjuvant
therapy did not adversely affect postoperative QOL at fol-
low-up 6 months after surgery, and other investigators
showed that patients who had surgery in combination with
adjuvant chemotherapy had equivalent EQ-5D utility score
compared with patients receiving surgery alone.31 Signifi-
cantly worse postoperative QOL after pneumonectomy com-
pared with lobectomy has been shown consistently by differ-
ent groups,2,8,27,28 and our finding that the extent of surgical
resection was a significant risk factor for a clinically relevant
decrease in the physical aspect of QOL was therefore in line
with prior research.
In conclusion, we found that the extent of surgery, age,
and adjuvant therapy, was predictive of a reduced postoper-
ative QOL 6 months after lung surgery. Other factors, i.e.,
gender, comorbidity, postoperative complications, and tumor
stage, were not associated with a higher risk for impaired
postoperative QOL. Our results were consistent with the
hypothesis that a clinically relevant decline in certain aspects
of health-related QOL can be predicted by factors know
before or early after surgery, but further studies are needed to
confirm these findings and to explore possible mechanisms.
TABLE 3. Associations Between Patient and Tumor Characteristics and Short Form 36 Summary
Scores 6 mo after Lung Surgery
Variable
No. of
Patients %
PCS MCS
OR 95% CI OR 95% CI
Total group 213
Stable or improved QOLa
No. of patients 87 143
% 41 67
Worse QOLa
No. of patients 126 70
% 59 33
Age
Younger than 65 yr
(reference)
101 47 1.00 1.00
65 yr and older 112 53 1.95 1.02–3.71 1.55 0.81–2.99
Gender
Female (reference) 104 49 1.00 1.00
Male 109 51 1.24 0.67–2.29 1.42 0.76–2.66
Comorbidity
No (reference) 117 55 1.00 1.00
Yes 96 45 0.73 0.38–1.38 0.80 0.42–1.56
Extent of resection
Sublobar resection
(reference)
46 22 1.00 1.00
Lobectomy 147 69 2.29 1.02–5.17 0.96 0.41–2.27
Pneumonectomy 20 9.4 5.60 1.29–24.2 1.26 0.37–4.31
Postoperative complication
No (reference) 165 77 1.00 1.00
Yes 48 23 2.13 0.95–4.81 1.78 0.84–3.78
Adjuvant therapy
No (reference) 147 69 1.00 1.00
Yes 66 31 2.23 1.01–4.90 1.85 0.85–3.99
Stage
0–I (reference) 138 65 1.00 1.00
II–III 75 35 1.62 0.74–3.50 1.06 0.50–2.25
Multivariable model adjusting for age, sex, comorbidity, type of operation, postoperative complications, adjuvant therapy, tumor stage,
and corresponding baseline Short Form 36 summary score.
a Worse QOL was defined as a summary score reduction of 10% or more, otherwise QOL was considered stable or improved.
PCS, physical component summary; MCS, mental component summary; OR, odds ratio; CI, confidence interval.
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